Mentor Capital, Inc. (MNTR) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mentor Capital, Inc. (MNTR) trades at $0.03. Mentor Capital, Inc. is a private equity firm focused on emerging growth investments, particularly in the cannabis sector. Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 15, 2026Analyst Coverage for MNTR: MNTR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MNTR against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on MNTR.
How is this calculated? →Mentor Capital, Inc. (MNTR) Financial Services Profile
Mentor Capital, Inc., founded in 1985, is a private equity firm specializing in pre-IPO investments, particularly within the cannabis industry. It focuses on providing capital and liquidity to emerging growth companies, primarily targeting those with sales exceeding $40 million for shelf IPOs, operating with a concentrated portfolio approach.
What Is the Investment Thesis for MNTR?
Mentor Capital's investment thesis centers on identifying and capitalizing on emerging growth opportunities within the cannabis industry. The firm's focus on pre-IPO investments allows it to potentially capture significant value appreciation as these companies mature and access public markets. Key to this thesis is the firm's ability to identify companies with strong earnings potential and the strategic deployment of capital to facilitate growth. However, the company's negative P/E ratio of -3.68 and a negative profit margin of -401.4% present challenges. Success hinges on the firm's ability to navigate the complex regulatory landscape of the cannabis industry and effectively manage its investments to achieve profitability.
Based on FMP financials and quantitative analysis
MNTR Key Highlights
Mentor Capital specializes in pre-IPO investments, particularly in the cannabis sector.
- The firm targets companies with sales exceeding $40 million for shelf IPOs.
- Mentor Capital takes significant positions in its portfolio companies.
- The company operates with a negative P/E ratio of -3.68.
- Mentor Capital has a negative profit margin of -401.4%.
Who Are MNTR's Competitors?
MNTR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BKLIF Blockmint Technologies Inc. | $0.01 | +400.00% | $17.4M | 48 |
| WDBG Woodbrook Group Holdings Inc. | $0.50 | +0.00% | 57 | |
| FDCT FDCTech, Inc. | $3.08 | -11.75% | $13.0M | 61 |
| CBTTF Cathedra Bitcoin Inc. | $0.46 | +25.16% | $13.4M | 56 |
| BBKCF BIGG Digital Assets Inc. | $0.05 | -6.09% | $16.5M | 62 |
| GSIW Garden Stage Limited provides financial services in Hong Kong, including securities dealing and brokerage, underwriting and placing, and asset management. The company | $16.80 | -0.74% | $23.7M | 61 |
| PLUT Plutus Financial Group Limited | $2.64 | -2.94% | $40.5M | 53 |
| STGC StartEngine Crowdfunding, Inc. | $0.15 | -94.83% | $113M | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MNTR's Key Strengths?
Specialized expertise in the cannabis industry.
- Focus on pre-IPO investments.
- Established network within the cannabis sector.
- Experience in providing capital to emerging growth companies.
What Are MNTR's Weaknesses?
Negative P/E ratio and profit margin.
- Small number of employees (2), indicating limited resources.
- Concentrated investment focus on the cannabis industry, increasing risk.
- OTC market listing, which can be associated with higher risk and lower liquidity.
What Could Drive MNTR Stock Higher?
Continued legalization of cannabis in new jurisdictions, expanding market opportunities.
- Increasing demand for capital in the cannabis industry, driving investment activity.
- Potential strategic acquisitions of complementary businesses to expand capabilities.
- Diversification into related sectors such as hemp and CBD to broaden market reach.
What Are the Key Risks for MNTR?
Financial-distress signal — its Altman Z-Score of -5.16 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-23.1%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Evolving and uncertain regulatory landscape for cannabis, creating compliance challenges.
- Increasing competition in the cannabis industry, impacting profitability.
- Changes in government policies regarding cannabis, affecting market dynamics.
- Negative P/E ratio and profit margin, indicating financial challenges.
- Limited liquidity due to OTC market listing, increasing price volatility.
What Are the Growth Opportunities for MNTR?
- Expansion within the Cannabis Industry: The ongoing legalization of cannabis in various jurisdictions presents a significant growth opportunity for Mentor Capital. As more states and countries legalize cannabis for medical and recreational use, the demand for capital and investment in this sector will continue to increase. Mentor Capital can leverage its expertise and experience in the cannabis industry to identify and invest in promising companies, driving growth and returns. The global legal cannabis market is projected to reach $57 billion by 2027.
- Strategic Acquisitions: Mentor Capital can pursue strategic acquisitions of complementary businesses to expand its capabilities and market reach. By acquiring companies with expertise in areas such as cannabis cultivation, processing, or distribution, Mentor Capital can create synergies and enhance its value proposition to portfolio companies. This strategy could involve acquiring smaller private equity firms with specialized knowledge in the cannabis sector.
- Diversification into Related Sectors: While Mentor Capital has a strong focus on the cannabis industry, diversifying into related sectors such as hemp or CBD could provide additional growth opportunities. These sectors share similar characteristics with the cannabis industry but may have different regulatory landscapes and market dynamics. By diversifying into these related sectors, Mentor Capital can reduce its reliance on the cannabis industry and capitalize on new growth opportunities.
- Enhanced Portfolio Management: Mentor Capital can improve its portfolio management practices to enhance the performance of its existing investments. This could involve providing portfolio companies with access to resources and expertise in areas such as marketing, sales, and operations. By actively managing its portfolio companies, Mentor Capital can help them achieve their growth objectives and increase the value of its investments. This includes active participation in strategic decision-making and operational improvements.
- Capitalizing on Regulatory Changes: The evolving regulatory landscape of the cannabis industry presents both challenges and opportunities for Mentor Capital. By staying abreast of regulatory changes and adapting its investment strategies accordingly, Mentor Capital can capitalize on new opportunities and mitigate potential risks. This could involve investing in companies that are well-positioned to comply with new regulations or that are developing innovative solutions to address regulatory challenges. The firm must closely monitor federal and state-level policy changes.
What Are MNTR's Competitive Advantages?
- Specialized expertise in the cannabis industry.
- Established network of relationships with companies and investors in the cannabis sector.
- Focus on pre-IPO investments, providing early access to potentially high-growth companies.
What Does MNTR Do?
Founded in 1985 and based in Ramona, California, Mentor Capital, Inc. operates as a private equity firm with a specific focus on acquiring and investing in emerging growth companies. The firm targets smaller companies and owners, particularly those in the medical, marijuana, and social-use cannabis sectors. Mentor Capital provides passive equity funding and liquidity, aiming to facilitate public market access for these businesses. Mentor Capital specializes in pre-IPO investments, particularly in cannabis companies, seeking to provide liquidity and growth capital. The firm prefers to invest in companies with sales greater than $40 million when considering shelf IPOs. Mentor Capital takes significant positions in its portfolio companies and invests exclusively in companies that have demonstrated earnings. This concentrated investment approach reflects a strategy of deep involvement and value creation within its chosen sectors.
What Products and Services Does MNTR Offer?
- Provide passive equity funding to smaller companies.
- Offer liquidity to owners in the medical, marijuana, and social-use cannabis sectors.
- Invest in shelf IPOs and public and private companies.
- Facilitate public market access for small private companies.
- Specialize in pre-IPO investments in cannabis companies.
- Take significant positions in portfolio companies.
- Invest only in companies that have earnings.
How Does MNTR Make Money?
- Invests in emerging growth companies, particularly in the cannabis sector.
- Provides capital and liquidity to these companies in exchange for equity.
- Generates returns through the appreciation of its equity investments as these companies grow and potentially go public.
What Industry Does MNTR Operate In?
Mentor Capital operates within the financial services sector, specifically in the capital markets and private equity segment. The firm's focus on the cannabis industry positions it within a high-growth but also highly regulated and competitive market. The cannabis market is characterized by evolving regulations, increasing competition, and significant growth potential as legalization expands. Mentor Capital's ability to navigate this complex landscape and identify promising investment opportunities will be critical to its success. Competitors include firms like BIDCF (BIDS Trading LP), BKBLF (Blackbird Capital), BKLIF (Black Iron), BLQC (BlockQuarry Corp), and CBTC (China Botanic Pharm Inc).
Who Are MNTR's Key Customers?
- Small to medium-sized private companies seeking capital for growth.
- Owners of private companies looking for liquidity and an exit strategy.
- Companies in the medical, marijuana, and social-use cannabis sectors.
Key Financial Metrics
Return on equity for Mentor Capital, Inc. stands at -23.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -19.5%, showing how much profit it generates from its asset base. Its free cash flow yield is -69.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 13.39 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -77.9%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Mentor Capital, Inc. operates in the Financial - Capital Markets industry within the Financial Services sector. It is headquartered in Plano, US. The company is led by CEO Chester Billingsley. MNTR has traded publicly since 2008.
Financial Health
Mentor Capital, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -5.16 places it in the distress zone, a signal of elevated financial risk.
Insider Activity
Over the past six months, Mentor Capital, Inc. insiders filed 15 SEC Form 4 transactions — 1 sales and 14 purchases. On net that is roughly 5.9M shares acquired (about $1K) — insiders putting money in tends to read as conviction.
MNTR Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Specialized expertise in the cannabis industry.
- Focus on pre-IPO investments.
- Established network within the cannabis sector.
- Experience in providing capital to emerging growth companies.
Bear Case
- Negative P/E ratio and profit margin.
- Small number of employees (2), indicating limited resources.
- Concentrated investment focus on the cannabis industry, increasing risk.
- OTC market listing, which can be associated with higher risk and lower liquidity.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
MNTR Latest News
No recent news available for MNTR.
MNTR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MNTR.
Price Targets
Wall Street price target analysis for MNTR.
MNTR MoonshotScore
What does this score mean?
The MoonshotScore rates MNTR 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Chester Billingsley
CEO
Chester Billingsley serves as the CEO of Mentor Capital, Inc. His background includes extensive experience in financial markets and investment management. He has a long history of working with emerging growth companies, particularly in identifying and capitalizing on opportunities in niche sectors. Billingsley's expertise lies in structuring investments and providing strategic guidance to portfolio companies to drive growth and create value.
Track Record: Under Chester Billingsley's leadership, Mentor Capital has focused on pre-IPO investments in the cannabis industry. Key milestones include the firm's strategic investments in several cannabis companies and its efforts to facilitate public market access for these businesses. Billingsley has overseen the firm's efforts to navigate the complex regulatory landscape of the cannabis industry and to identify promising investment opportunities.
MNTR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Mentor Capital may not meet the minimum financial standards or disclosure requirements of the higher tiers (OTCQX and OTCQB). Companies in this tier may have limited financial reporting, and trading activity can be sporadic. Investing in companies on the OTC Other tier carries a higher degree of risk compared to companies listed on major exchanges like the NYSE or NASDAQ, due to the limited information available and the potential for less stringent regulatory oversight.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for price manipulation and fraud.
- Higher risk of delisting or suspension of trading.
- Less regulatory oversight compared to major exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their track record.
- Research the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Determine the company's ownership structure and potential conflicts of interest.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Company has been in business since 1985.
- Focus on pre-IPO investments, suggesting a long-term investment strategy.
- Specialized expertise in the cannabis industry.
- CEO with experience in financial markets and investment management.
Mentor Capital, Inc. Financial Services Stock: Key Questions Answered
What does Mentor Capital, Inc. do?
Mentor Capital, Inc. is a private equity firm that specializes in providing capital and liquidity to emerging growth companies, particularly in the medical, marijuana, and social-use cannabis sectors. The firm focuses on pre-IPO investments, aiming to facilitate public market access for these businesses.
What are the main risks for MNTR?
The main risks for Mentor Capital include the evolving and uncertain regulatory landscape for cannabis, increasing competition in the cannabis industry, and potential changes in government policies regarding cannabis. The company's negative P/E ratio and profit margin also pose significant financial risks.
What are the key factors to evaluate for MNTR?
Evaluate MNTR on fundamentals, analyst consensus, and risk factors. Mentor Capital's investment thesis centers on identifying and capitalizing on emerging growth opportunities within the cannabis industry. Not financial advice.
How frequently does MNTR data refresh on this page?
MNTR's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven MNTR's recent stock price performance?
Mentor Capital, Inc. (MNTR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in the cannabis industry. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MNTR overvalued or undervalued right now?
Mentor Capital, Inc. (MNTR) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research MNTR before investing?
Before investing in Mentor Capital, Inc. (MNTR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding MNTR to a portfolio?
Key strength of Mentor Capital, Inc. (MNTR): Specialized expertise in the cannabis industry. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for Mentor Capital, Inc. due to its OTC listing.
- AI analysis pending, limiting the availability of analyst insights.